GlassScriptPhysician profile
Dhaval Jivanji
NPI 1619661923
$1,353.59
in general payments reported to CMS, 2019-2025
10 companies · $564 in 2025
The $564 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $593 · 2024: $197 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $425.34 | 2023 | Prolaris |
| Boston Scientific Corporation | $234.60 | 2023-2024 | Rezum Generator, Ams 700, Spaceoar Vue System - 10ml |
| Innovation Technologies INC | $172.10 | 2025 | Irrisept |
| Immunitybio, INC. | $146.31 | 2025 | |
| Urogen Pharma, INC. | $144.18 | 2024-2025 | |
| Teleflex LLC | $83.86 | 2025 | Barrigel |
| Pfizer INC. | $57.86 | 2023-2025 | |
| Blue Earth Diagnostics | $54.59 | 2024-2025 | Posluma |
| Janssen Biotech, INC. | $20.62 | 2025 | Erleada |
| Olympus America INC. | $14.13 | 2023 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaval Jivanji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.